A scientist quit Stanford to chase a new way to treat depression. He just shared an early sign that his approach could work.

Jan 10 2023 by Business Insider

 
Dr. Amit Etkin is the founder and CEO of Alto Neuroscience.

Alto Neuroscience

Alto Neuroscience is focused on developing precision medicine for mental health. On Tuesday, the company announced some promising signs for its treatment ALTO-100. The drug is geared toward treating a subgroup of patients with depression.

In 2019, Dr. Amit Etkin left Stanford University to pursue a new way to treat psychiatric disorders like depression and post-traumatic stress disorder.

While many treatments for...

Continue Reading A scientist quit Stanford to chase a new way to treat depression. He just shared an early sign that his approach could work.